Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Neil B Desai
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
576 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arthur J E Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- Chu de Quebec-L'Hotel-Dieu de Quebec (hdq)
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Arizona Center for Cancer Care - Gilbert
Gilbert, Arizona, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Arizona Center for Cancer Care-Peoria
Peoria, Arizona, United States
- Arizona Center for Cancer Care - Phoenix
Phoenix, Arizona, United States
- Arizona Center for Cancer Care - Scottsdale
Scottsdale, Arizona, United States
- Arizona Center for Cancer Care-Surprise
Surprise, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Ais Cancer Center at San Joaquin Community Hospital
Bakersfield, California, United States
- Tower Cancer Research Foundation
Beverly Hills, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- City of Hope Corona
Corona, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Uc San Diego Health System - Encinitas
Encinitas, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Washington Hospital
Fremont, California, United States
- Kaiser Permanente Fresno Orchard Plaza
Fresno, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Marin General Hospital
Greenbrae, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Kaiser Permanente- Modesto Mob Ii
Modesto, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Dec 2021
- Primary completion
- 11 Nov 2026
- Completion
- 11 Nov 2026
- Last update posted
- 25 Jun 2026
- Registered enrollment
- 2,050
- Registry id
- NCT05050084
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.